FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Morton Grove Pharmaceuticals Dexamethasone Elixir Recall

Dexamethasone Elixir, USP 0

Morton Grove Pharmaceuticals, Inc. · Morton Grove, IL

Risk level
Class II
Reported by FDA
Mar 9, 2022
Recall ID
D-0713-2022
Check your lot numberHow we source this data

Summary

Morton Grove Pharmaceuticals recalled Dexamethasone Elixir starting Feb 21, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0713-2022 on Mar 9, 2022. Reason: Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.

Product description

Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08.

Lot numbers, UPCs & expiration codes

Lot #s: UV1004, UV1005, Exp 6/22; UW1014, UW1015, Exp 1/23; UW1084, Exp 7/23

Where it was sold

Nationwide USA and Puerto Rico

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0713-2022
Classification
Class II
Status
Terminated
Recall initiated
Feb 21, 2022
FDA report date
Mar 9, 2022
Recall type
Voluntary: Firm initiated
Recalling firm
Morton Grove Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0713-2022, exactly as published.

Show all FDA fields
City
Morton Grove
State
IL
Status
Terminated
Country
United States
Event ID
89624
Address
6451 Main St
Code information
Lot #s: UV1004, UV1005, Exp 6/22; UW1014, UW1015, Exp 1/23; UW1084, Exp 7/23
Postal code
60053-2633
Report date
Mar 9, 2022
Product type
Drugs
Recall number
D-0713-2022
Classification
Class II
Recalling firm
Morton Grove Pharmaceuticals, Inc.
Termination date
Aug 6, 2024
Reason for recall
Failed Impurities/Degradation Specifications: higher than permissible levels of unknown impurities were found in the drug product.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dexamethasone Elixir, USP 0.5 mg/5 mL, Net: 8 fl oz (237 mL) bottle, Rx only, Manufactured By: Morton Grove Pharmaceuticals, Inc., Morton Grove, IL 60053, NDC 60432-466-08.
Distribution pattern
Nationwide USA and Puerto Rico
Recall initiation date
Feb 21, 2022
Initial firm notification
Letter
Center classification date
Mar 21, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0713-2022, published Mar 9, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls